Join Our Newsletter

Northwest Biotherapeutics, Inc. - NWBO

RSI %R Tweets Wolf Odds
56 -52 26 78.81%

Industry: Biotechnology / Sector: Healthcare

NWBO Chart

NWBO Quote

Prev Close: 0.272
Open: 0.2715
Last Trade: 0.2698
Change %: -0.810%
Change: -0.0022000
Volume: 388045
Avg Vol: 1937553
Relative Vol: 0.20
Day Range: 0.261 -0.28
52-Week Range: 0.1400 - 0.9800
Market Cap: 50.28M
Float: 249.83M
Shares Outstanding: 315.12M
Insider Owned: 5.81%
Institution Owned: 18.92%
Beta: 1.53
PE Ratio: 0.00
EPS: -0.3940

NWBO Detailed Stats

RSI:55.62 %K:47.92 Wolf Odds: 78.81% Tweets Today:26 SMA14:0.2700
stochRSI:0.31 %D:49.02 Wolf Trend:0.13 Tweet Avg:61 Pivot Price:0.2702667
%R:-52.08 %B:0.50 Wolf 3-Day:0.33 Avg. Change 3-Day:-0.633% Resistance 1:0.2795333
MFI:46.25 Bandwidth:0.235185 Wolf 7-Day:0.40 Avg. Change 7-Day:+0.737% Resistance 2:0.2892667
WolfPeak:0.20 Vortex Indicator:0.02 Wolf 14-Day:0.54 Avg. Change 14-Day:+0.18% Support 1:0.2605333
ROC 7/14:4.5736/-9.1582 Aroon Oscillator:-42.8571 EOM:0.006524 Relative Vol:0.20 Support 2:0.2512667
RSI Alert:None WolfPeak Alert:None Vortex Alert:Potential Bear Aroon Alert:None EOM Alert:None

Featured News *


NWBO Description

Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient?s own immune system to attack cancer. It is developing DCVax-L, a product in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, a product in Phase I/II clinical trials to treat various types of inoperable solid tumor cancers. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

NWBO Comments

Recent NWBO Tweets

Powered by Ekonomys ver. 9

StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell